Print

IAVI R001

Phase 1 Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine

Trial Details:

I Completed
International AIDS Vaccine Initiative (IAVI) January 15, 2015
rcAd26.MOS1.HIVEnv Oral, Replicating Ad26 mosiac Env
rcAd26.MOS1.HIVEnv Viral Vector - Replicating
USA 24
NCT02366013
https://www.clinicaltrials.gov/ct2/show/NCT02366013?term=hiv+and+vaccine&lup_s=02%2F10%2F2015&lup_d=14&show_rss=Y&sel_rss=mod14